Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M390Revenue (TTM) $M7.0Net Margin (%)-622.7Altman Z-Score-0.4
Enterprise Value $M268EPS (TTM) $-1.0Operating Margin %-631.1Piotroski F-Score4
P/E(ttm)--Beneish M-Score1.6Pre-tax Margin (%)-622.7Higher ROA y-yN
Price/Book7.210-y EBITDA Growth Rate %--Quick Ratio4.7Cash flow > EarningsY
Price/Sales54.45-y EBITDA Growth Rate %73.5Current Ratio4.7Lower Leverage y-yY
Price/Free Cash Flow9.8y-y EBITDA Growth Rate %--ROA % (ttm)-43.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-66.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M47.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CCXI

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CCXI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CCXI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bekker PetrusChief Medical Officer 2016-11-22Sell1,250$8.3-1.69view
Bekker PetrusChief Medical Officer 2016-11-11Sell33,332$82view
LUCAS ROGER CDirector 2016-11-01Sell4,000$6.133.77view
LUCAS ROGER CDirector 2016-09-01Sell4,000$5.0760.95view
Tyree James LDirector 2016-05-23Sell5,544$4.3985.88view
Edwards Thomas A.Director 2016-05-17Buy50,000$4.05101.48view
Edwards Thomas A.Director 2016-05-16Buy25,000$4.05101.48view
Parker Geoffrey M.Director 2016-05-13Buy40,000$4.03102.48view
KANAYA SUSAN MSVP, Finance, CFO and Sec. 2016-01-22Sell25,764$4.04101.98view
KANAYA SUSAN MSVP, Finance, CFO and Sec. 2016-01-20Sell21,405$4.08100view

Quarterly/Annual Reports about CCXI:

News about CCXI:

Articles On GuruFocus.com
Immune Design Insider Buys Shares Oct 03 2016 
Three Attractively Priced Small Cap Biotech Stocks Nov 05 2014 

More From Other Websites
Everyday Health Inc (EVDY), ANSYS, Inc. (ANSS), More: Why You Should Pay Attention To These Stocks Nov 16 2016
CHEMOCENTRYX, INC. Financials Nov 16 2016
CHEMOCENTRYX, INC. Files SEC form 10-Q, Quarterly Report Nov 08 2016
Edited Transcript of CCXI earnings conference call or presentation 7-Nov-16 10:00pm GMT Nov 08 2016
ChemoCentryx reports 3Q loss Nov 07 2016
ChemoCentryx reports 3Q loss Nov 07 2016
CHEMOCENTRYX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 07 2016
ChemoCentryx Reports Third Quarter 2016 Financial Results and Provides Corporate Update Nov 07 2016
ChemoCentryx to Hold Third Quarter 2016 Financial Results Conference Call on Monday, November 7,... Nov 07 2016
ChemoCentryx Announces Presentations of Positive Results from Phase II ANCA-Associated Vasculitis... Nov 07 2016
Q3 2016 ChemoCentryx Inc Earnings Release - After Market Close Nov 07 2016
ChemoCentryx to Hold Third Quarter 2016 Financial Results Conference Call on Monday, November 7,... Oct 28 2016
ChemoCentryx Reports Improvement in Renal Physiology and Stabilization of Kidney Function Following... Oct 27 2016
CHEMOCENTRYX, INC. Files SEC form 8-K, Change in Directors or Principal Officers Oct 25 2016
CHEMOCENTRYX, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD... Oct 20 2016
ChemoCentryx Appoints Henry A. McKinnell, Jr. to Board of Directors Oct 20 2016
ChemoCentryx’s CCR2 Inhibitor CCX872 Shown to Reduce Liver Fibrosis in NASH Models Oct 18 2016
ChemoCentryx Announces Presentation of Positive Data from Ongoing Pilot Phase II Trial of CCX168... Oct 17 2016
Healthcare-Focused Michael Castor Added These Stocks to His Portfolio Last Quarter Sep 27 2016
Edited Transcript of CCXI earnings conference call or presentation 8-Aug-16 9:00pm GMT Aug 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)